title: [The appreciation of bone growth factor in women with osteoporosis exposing on freetransition magnetic field].
abstract: In spite of many news bulletin of favorable influence of freetransition magnetic field on regeneration bone tissue, there is lack of information of function mechanism on bone metabolism. The aim of this work was to evaluate the concentrations of bone growth factors (osteokalcin, prokolagen, estrogens) and mineral density of cervical bone in women expose on freetransition magnetic field. 40 women were treatment age 50-55 in postmenopause period divided in two groups: I--control group, age 51.3+/-2.6 seemingly exposed on freetransition magnetic field 12 minutes a day 30 days, and then 24 minutes of expose per week 150 days; II--group age 53.4+/-1.9, exposed on freetransition magnetic field generationed by Viofor JPS (Med. and Life) with the time of exposition like in group I. Before and after the concentrations of estron, estradiol, osteokalcyn, prokolagen, total and ionize calcium, phosphor ion in plasma in both groups were examined. Mineral density of cervical bone was examined before treatment and after 12 month DEXA method (Lunar DPX). There was insignificant increase of concentration osteokalcyn, prokolagen, insignificant decrease total and ionize calcium, significant increase of concentration of estron, estradiol (p<0.05) and mineral density of cervical bones (0.001) in group exposed on freetransition magnetic field. There are no differences between concentration of calcium and phosphor in women from two groups.
authors.affiliation: Pracownia Menopauzy i Andropauzy PAM.
authors.forename: Stanisław
authors.initials: S
authors.lastname: Stanosz
authors.forename: Małgorzata
authors.initials: M
authors.lastname: Stanosz
authors.forename: Kazimierz
authors.initials: K
authors.lastname: Wysocki
mesh_terms: D000328:Adult; D015519:Bone Density; D002118:Calcium / Q000097:blood; D004574:Electromagnetic Fields; D055590:Electromagnetic Phenomena / Q000295:instrumentation; D004867:Equipment Design; D004967:Estrogens / Q000378:metabolism; D005260:Female; D006801:Humans; D007335:Insulin-Like Growth Factor II; D008875:Middle Aged; D015675:Osteocalcin / Q000378:metabolism; D010024:Osteoporosis / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy*; D010758:Phosphorus / Q000097:blood; D010949:Plasma; D011347:Procollagen / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*; D012720:Severity of Illness Index
chemical_list: D004967:Estrogens; C035170:IGF2 protein, human; D011347:Procollagen; D011506:Proteins; D015675:Osteocalcin; D010758:Phosphorus; D007335:Insulin-Like Growth Factor II; D002118:Calcium